gog-0218: which patients with ovarian cancer experience highest benefit from 1l bevacizumab?
Published 2 years ago • 663 plays • Length 3:47Download video MP4
Download video MP3
Similar videos
-
6:03
gog-0218: frontline bevacizumab in ovarian cancer
-
0:47
bevacizumab for the treatment of patients with ovarian cancer exhibiting poor chemosensitivity
-
4:43
understanding gog-0218 & icon7 trials
-
3:56
treatment ovarian cancer with novel targeted therapies and io
-
6:10
ago-ovar 2.29/engot-ov34: atezolizumab vs placebo bevacizumab w/ chemo recurrent ovarian cancer
-
4:25
adjuvant chemotherapy bevacizumab for ovarian cancer
-
23:15
is it time to change upfront chemotherapy for ovarian cancer?
-
4:04
gog-0218 and icon7 trial regimens as maintenance therapy
-
0:59
my ovarian cancer symptoms! "i was tired and stressed!"
-
1:13
final os results from paola-1 evaluating 1l maintenance olaparib plus bevacizumab
-
1:19
real-world use of bevacizumab in patients with breast cancer
-
33:15
ovarian cancer: standards of care and new opportunities - dr. robert coleman
-
7:09
biomarker-driven frontline ovarian cancer treatment
-
0:48
my shocking symptom of ovarian cancer
-
1:10
rebastinib and paclitaxel for advanced/metastatic ovarian cancer
-
1:12
dr. herzog on the optimal use of bevacizumab in patients with ovarian cancer
-
2:27
the paola-1 study: olaparib and bevacizumab for ovarian cancer
-
2:50
aurelia: phase 3 trial of bevacizumab combined with chemotherapy for ovarian cancer
-
1:50
dr. birrer on the ovarian cancer avastin os benefit